Blog / Archives
ASCO Day 3: News and Daily Movers in Risk-Off Mode CELG,GILD,IBB,PCYC
Market Correction Is Here-IBB at 170 off 2%+ The biotech sector sell-off (IBB at $170) continues today despite an effort to rally in the opening (IBB at $178). The biotech sector now tracks the...
ASCO Day 2 Briefs and Daily Movers: ARRY,GILD,IBB,IMGN,SGEN
Apparently ASCO Is "Sell On the News" Trigger Another lackluster trading day with profit taking; the IBB is down 2.3% and trading near its May bottom with a pronounced topping pattern.Moreover many...
ASCO News and Moves: BMRN, BMY, CLDX, MRK, ONXX, SGEN Update 1 CLVS
Sell On ASCO News Due to High Expectations? Large Cap Drugs Outperform Biotechs As we move through the first day of ASCO and much anticipated clinical developments the market should not be surprised...
Reiterate Caution on Biopharmaceutical Stocks With Major 3% Sector Sell-Off
Raise More Cash- No Change in Rayno Biopharma Portfolio Last month we raised the yellow flag on the biotech sector because of a choppy tape, new highs with weakness in MO (Momentum) plays and the...
Rayno Life Science DX and Tools: Performance YTD 5/28
Rayno Diagnostics and Tools Portfolio Rayno Life Science top picks were up 20 to 53% beating the NASDAQ and S&P. Five new stocks were added in 2013: BG Medicine (BGMD), Genomic Health...
Biotech and Drug Stocks Down as Investors Trim Positions
Biopharmaceutical Stocks Sell-Off with Large Cap Drug Stocks High Flyers du jour-AEGR,INFI 10 Year Treasury Hits 2.13 Yield Caution-no new buys and all portfolio positions on hold Large cap drug...
Rayno Life Science Dx and Tools-Green Day with New Highs-GHDX, NEOG,TMO
Impressive Rally in Diagnostics and Tools Stocks The NASDAQ rally is beginning to fade now up only 17 pts after hitting a high of 3510 at 10 am EDT. However many Life Science Tools and Diagnostics...
Reversal Day-Caution is Back-NASDAQ Down 1% or 35Pts– Update 5/23
Biotechs Bounce Back After Deep Dive Unless you were trading at the open today and covered your shorts you could have been whipsawed in a volatile market that had NASDAQ down to the 3425 level. Many...
When Does the Cost of Cancer Drugs Affect the Market?
Cancer's Bitter Medicine Alex Philippidis in today's Genetic Engineering News provides an excellent review of the treatment costs for CML (chronic myeloid leukemia) which can exceed $100k/year....
Rayno Life Science: Bringing on the Green After a Four Day Rest
Biopharmaceutical Stocks Rally- Many Rayno Picks up 2%+ If the past four days was the long awaited biotechnology correction it was barely noticeable, a mere 3.7% high to low over the past week.Today...